Market Overview
The Global Compression Therapy Market size is expected to be valued at USD 4.4 billion in 2025, and is projected to reach USD 6.2 billion by 2034, growing at a steady CAGR of 3.9%. This growth is largely driven by the rising incidence of chronic venous disorders, lymphedema, and diabetic ulcers, particularly among the aging population. As awareness around vascular health and the need for effective wound care management grows, so does the demand for compression garments, pneumatic compression devices, and multilayer bandaging systems.
Compression therapy is a clinically proven method that involves the application of external pressure to specific areas of the body, primarily the limbs, to improve blood circulation and reduce fluid buildup. It is widely used in the treatment of various vascular and lymphatic conditions such as lymphedema, varicose veins, chronic venous insufficiency, and deep vein thrombosis. This therapy relies on medical-grade compression garments, multilayer bandages, and intermittent pneumatic compression devices to promote venous return and minimize venous stasis. By facilitating efficient blood flow and preventing fluid accumulation, compression therapy aids in faster wound healing, particularly in cases of venous leg ulcers and diabetic foot ulcers. It is also commonly prescribed after surgical procedures to reduce the risk of thromboembolic events and improve recovery outcomes. The growing preference for non-invasive, cost-effective treatment options has further boosted the adoption of compression therapy in both clinical and home settings across the world.
The global compression therapy market is experiencing significant growth, primarily fueled by the rising prevalence of chronic conditions linked to poor circulation and vascular dysfunction. An aging global population, integrated with the surge in lifestyle diseases such as obesity, diabetes, and hypertension, has led to a higher incidence of venous and lymphatic disorders that require long-term management. Patients are turning to compression therapy as a first-line treatment due to its ability to alleviate symptoms, improve mobility, and reduce complications without relying heavily on pharmaceuticals or surgical intervention. The rising awareness of early intervention in vascular care and the growing demand for patient-centric solutions have created strong momentum for the market.
Technology advancements in compression products are playing a pivotal role in shaping the future of the market. Manufacturers are innovating with breathable fabrics, adjustable compression levels, and wearable compression systems that offer enhanced comfort and therapeutic effectiveness. Smart compression devices integrated with digital monitoring tools are gaining popularity, especially among home care users seeking convenience and real-time feedback. In addition, the expansion of telehealth services and remote patient management is making compression therapy more accessible to a wider patient population. These innovations, along with favorable reimbursement policies in several developed economies, are encouraging healthcare providers to recommend compression therapy as part of holistic care for chronic wounds, post-operative recovery, and sports-related injuries.
The US Compression Therapy Market
The U.S. Compression Therapy Market size is projected to be valued at USD 1.6 billion in 2025. It is further expected to witness subsequent growth in the upcoming period, holding USD 2.2 billion in 2034 at a CAGR of 3.7%.
The U.S. compression therapy market is witnessing strong momentum, driven by the rising prevalence of chronic venous insufficiency, lymphedema, and other circulatory disorders. With an aging population and a growing number of individuals affected by sedentary lifestyles and obesity, the demand for non-invasive therapeutic solutions is escalating. Compression garments such as gradient compression stockings, wraps, and socks are widely recommended by healthcare providers for improving venous return and preventing complications like deep vein thrombosis. In parallel, intermittent pneumatic compression devices are gaining traction in both hospital settings and home care, especially for post-surgical recovery and the prevention of leg ulcers.
The growing burden of diabetic foot ulcers and vascular complications has made compression therapy a critical component in chronic wound management. Physicians and wound care specialists are integrating compression-based protocols into treatment plans to accelerate healing and reduce the recurrence of ulcers. In rehabilitation centers and physical therapy clinics, the use of compression sleeves and bandages is becoming standard practice for treating sports injuries, joint swelling, and post-traumatic edema. The U.S. healthcare ecosystem, which emphasizes early intervention and outpatient care, has created a favorable environment for the widespread adoption of compression therapy solutions.
The European Compression Therapy Market
The European compression therapy market is projected to reach approximately USD 1.3 billion in 2025, with an anticipated CAGR of 3.5% during the forecast period. This growth is driven by several factors, including the region's aging population, growing prevalence of chronic venous diseases, and advancements in healthcare infrastructure.
One of the primary drivers of the European compression therapy market is the region’s aging population. As Europe has one of the most rapidly aging populations globally, the demand for compression therapy products, such as compression stockings, bandages, and pneumatic compression devices, continues to grow. Older adults are more prone to conditions like varicose veins, venous leg ulcers, and lymphedema, which often require long-term management through compression therapy. With a substantial portion of the population over the age of 60, especially in countries like Germany, Italy, and France, the demand for effective and comfortable compression therapy solutions is expected to rise.
Moreover, the growing awareness of vascular health and chronic venous disease in Europe is contributing to the expansion of the market. Medical professionals, patients, and caregivers are becoming more aware of the benefits of compression therapy, not only as a treatment but also as a preventive measure for individuals at risk of developing circulatory issues. This shift in healthcare mindset is pushing for better adoption rates of compression garments and devices across the continent.
The Japan Compression Therapy Market
The compression therapy market in Japan is projected to reach a market size of USD 0.3 billion in 2025, with an expected CAGR of 4.5% during the forecast period. This growth is driven by several factors, including the country’s rapidly aging population, growing prevalence of chronic venous conditions, and the rising awareness of the benefits of compression therapy.
One of the primary drivers for the growth of the compression therapy market in Japan is its aging population. Japan has one of the oldest populations in the world, with a significant portion of the population aged 65 and older. As the elderly population grows, the demand for products that can manage chronic conditions such as varicose veins, lymphedema, and deep vein thrombosis (DVT) is growing. Older adults are more susceptible to these vascular conditions, and as a result, compression therapy is becoming a critical part of their management plans. The demand for compression stockings, bandages, and pneumatic compression devices is expected to rise as more elderly individuals seek effective solutions to alleviate symptoms of these conditions.
Additionally, Japan’s well-developed healthcare infrastructure plays a pivotal role in driving market growth. With advanced medical technology and high standards of care, Japanese consumers and healthcare professionals are adopting medical-grade compression therapy products. Hospitals, clinics, and rehabilitation centers across Japan are integrating compression therapy into their treatment protocols for conditions related to poor blood circulation, leading to a higher adoption rate of these products.
Global Compression Therapy Market: Key Takeaways
• Market Value: The global compression therapy size is expected to reach a value of USD 6.2 billion by 2034 from a base value of USD 4.4 billion in 2025 at a CAGR of 3.9%.
• By Technique Segment Analysis: Static Compression Therapy is expected to maintain its dominance in the technique segment, capturing 68.9% of the total market share in 2025.
• By Product Type Segment Analysis: Compression Bandages are poised to consolidate their dominance in the product type segment, capturing 38.2% of the total market share in 2025.
• By Application Segment Analysis: Varicose Veins treatment applications are anticipated to maintain their dominance in the application type segment, capturing 34.5% of the total market share in 2025.
• By Distribution Channel Type Segment Analysis: Hospitals and Clinics are poised to consolidate their dominance in the distribution channel type segment, capturing 52.8% of the market share in 2025.
• Regional Analysis: North America is anticipated to lead the global compression therapy market landscape with 42.2% of total global market revenue in 2025.
• Key Players: Some key players in the global compression therapy market are 3M, Smith & Nephew, Medtronic, BSN Medical (Essity), Sigvaris Group, medi GmbH & Co. KG, Juzo (Julius Zorn GmbH), Paul Hartmann AG, Mölnlycke Health Care AB, Bio Compression Systems, Inc., Cardinal Health, Tactile Systems Technology, Inc. (Tactile Medical), Arjo, Thuasne Group, DJO Global (Enovis), Sanyleg S.r.l., Gottfried Medical, Inc., Devon Medical Products, BTL Industries, Talley Group Ltd, and Other Key Players.
Global Compression Therapy Market: Use Cases
• Chronic Venous Insufficiency and Venous Leg Ulcer Management: Compression therapy is a first-line treatment for patients suffering from chronic venous insufficiency and venous leg ulcers. These conditions often arise due to malfunctioning venous valves that lead to blood pooling in the lower extremities. By applying graduated pressure through compression stockings, bandages, or wraps, the therapy promotes efficient venous return, reduces edema, and supports tissue regeneration. Multilayer compression systems and medical-grade compression garments are frequently used in both hospital and outpatient wound care clinics to accelerate healing and prevent ulcer recurrence. The growing burden of vascular diseases and the demand for cost-effective, non-invasive therapies are making compression therapy an essential part of chronic wound management across global healthcare systems.
• Lymphedema Treatment and Lymphatic Drainage: Compression therapy plays a vital role in the treatment of lymphedema, a condition characterized by the accumulation of lymphatic fluid, leading to swelling typically in the arms or legs. Patients suffering from primary or secondary lymphedema, often due to cancer treatment or lymph node removal, benefit from the use of compression sleeves, wraps, and pneumatic compression devices. These tools assist in fluid mobilization and help prevent tissue hardening and infections. Manual lymphatic drainage combined with intermittent pneumatic compression is becoming a standard care protocol in physical therapy and rehabilitation centers. As awareness of lymphedema grows globally, so does the adoption of therapeutic compression solutions to enhance mobility and improve patient quality of life.
• Post-Surgical Recovery and Thromboprophylaxis: Post-operative patients, particularly those recovering from orthopedic surgeries or prolonged immobility, are at high risk of developing deep vein thrombosis (DVT). Compression therapy, particularly through the use of pneumatic compression devices and anti-embolism stockings, is widely used for thromboprophylaxis. By stimulating circulation and preventing blood stasis, these devices lower the risk of clot formation. In surgical wards and intensive care units, healthcare providers implement compression therapy as part of Enhanced Recovery After Surgery (ERAS) protocols. This not only improves outcomes but also reduces hospital stay durations and associated healthcare costs. The increased focus on post-surgical care and patient safety is significantly driving the demand for compression solutions in perioperative settings.
• Sports Medicine and Injury Rehabilitation: Compression therapy has become an integral part of modern sports medicine and physical rehabilitation. Athletes and active individuals use compression garments such as calf sleeves, arm sleeves, and ankle wraps to manage soft tissue injuries, reduce muscle fatigue, and enhance recovery after intense physical activity. These garments aid in reducing lactic acid buildup and improving oxygen delivery to muscles. In cases of ligament injuries or sprains, compression bandages help control inflammation and stabilize the affected area. The growing emphasis on performance optimization and injury prevention in professional and recreational sports is boosting the use of therapeutic compression as a non-pharmacologic recovery aid. With wearable technology and smart fabrics entering the market, the integration of compression therapy in sports recovery is only expected to expand further.
Global Compression Therapy Market: Stats & Facts
• Centers for Disease Control and Prevention (CDC), United States
o Deep Vein Thrombosis (DVT): Affects up to 900,000 people annually in the U.S.
o Chronic Venous Insufficiency (CVI): Affects more than 25 million people in the U.S.
o Diabetes Prevalence: 38.4 million people, or 11.6% of the U.S. population, have diabetes.
o Healthcare Spending: U.S. healthcare spending grew by 4.1% in 2022, reaching USD 4.5 trillion.
• National Institutes of Health (NIH), United States
o Peripheral Artery Disease (PAD): Prevalence increased from 11.3 million in 1995 to an estimated 26 million in 2020.
• America’s Health Rankings
o Aging Population: Approximately 58 million adults aged 65 and above currently reside in the U.S., constituting around 17.3% of the nation's population.
• Centers for Medicare & Medicaid Services (CMS), United States
o Healthcare Spending: By July 2024, U.S. healthcare spending grew by 4.1% in 2022, reaching USD 4.5 trillion or USD 13,493 per person.
• Lymphatic Education & Research Network (LE&RN), United States
o Lymphedema Prevalence: Approximately 10 million Americans suffer from lymphedema.
• National Center for Biotechnology Information (NCBI), United States
o Lymphedema Global Prevalence: Affects approximately 250 million patients worldwide.
o Venous Leg Ulcer Prevalence: Affects around 1.5% of the general population and up to 5% of the geriatric population.
• National Highway Traffic Safety Administration (NHTSA), United States
o Motor Vehicle Accidents: An estimated 20,175 people died in motor vehicle crashes in 2022, an increase of about 0.5% from 2021.
• U.S. Food and Drug Administration (FDA), United States
o Product Approvals: In April 2023, Airos Medical, Inc. received U.S. FDA 510(k) clearance to market their AIROS 8P Sequential Compression Therapy garment system and device.
• National Health Service (NHS), United Kingdom
o Compression Therapy Guidelines: The NHS provides guidelines on the use of compression therapy for conditions like venous leg ulcers and lymphedema.
o Compression Bandage Usage: Recommends the use of multi-layered compression bandages for effective management of venous leg ulcers.
• Australian Government Department of Health
o Chronic Venous Disease: The department acknowledges chronic venous disease as a significant health issue, recommending compression therapy as a primary treatment.
o Lymphedema Management: Supports the use of compression garments in the management of lymphedema.
• World Health Organization (WHO)
o Chronic Diseases: Highlights the increasing global burden of chronic diseases, including those requiring compression therapy.
o Healthcare Access: Emphasizes the need for equitable access to healthcare services, including treatments like compression therapy.
• European Commission
o Healthcare Expenditure: Reports on the rising healthcare expenditure across EU member states, impacting the adoption of various treatments, including compression therapy.
o Regulatory Standards: Sets regulatory standards for medical devices, including compression therapy products, ensuring safety and efficacy.
• Public Health Agency of Canada
o Chronic Disease Management: Supports the use of compression therapy in managing chronic diseases prevalent in the Canadian population.
o Healthcare Guidelines: Provides guidelines on the use of compression therapy for conditions like venous leg ulcers and lymphedema.
• National Institute for Health and Care Excellence (NICE), United Kingdom
o Compression Therapy Recommendations: Recommends compression therapy as a first-line treatment for venous leg ulcers.
o Cost-Effectiveness Analysis: Conducts cost-effectiveness analyses to support the use of compression therapy in the NHS.
• Health Canada
o Medical Device Regulations: Regulates medical devices, including compression therapy products, ensuring they meet safety and efficacy standards.
o Public Health Initiatives: Supports public health initiatives that promote awareness and use of compression therapy for chronic conditions.
• Australian Institute of Health and Welfare (AIHW)
o Chronic Disease Data: Provides data on the prevalence of chronic diseases in Australia, underscoring the need for treatments like compression therapy.
o Healthcare Utilization: Reports on healthcare utilization patterns, including the use of compression therapy services.
• Ministry of Health, Labour and Welfare (MHLW), Japan
o Aging Population Statistics: Reports on the aging population in Japan, highlighting the increased need for healthcare services, including compression therapy.
o Healthcare Policy: Develops healthcare policies that support the use of compression therapy for managing chronic conditions.
• National Institute of Public Health (NIPH), Japan
o Chronic Disease Prevalence: Monitors the prevalence of chronic diseases in Japan, indicating a growing demand for treatments like compression therapy.
o Health Promotion Programs: Initiates health promotion programs that include education on the benefits of compression therapy.
• Korean Centers for Disease Control and Prevention (KCDC), South Korea
o Chronic Disease Surveillance: Conducts surveillance on chronic diseases, identifying trends that influence the adoption of compression therapy.
o Public Health Guidelines: Issues public health guidelines that incorporate compression therapy for managing certain conditions.
• Indian Council of Medical Research (ICMR), India
o Chronic Disease Research: Conducts research on chronic diseases prevalent in India, informing the need for treatments like compression therapy.
o Healthcare Recommendations: Provides healthcare recommendations that include the use of compression therapy for specific conditions.
• Ministry of Health and Family Welfare, India
o Healthcare Policies: Develops healthcare policies that support the integration of compression therapy into treatment protocols.
o Public Health Campaigns: Launches public health campaigns to raise awareness about the benefits of compression therapy.
• Brazilian Ministry of Health
o Chronic Disease Management: Supports the use of compression therapy in managing chronic diseases prevalent in Brazil.
o Healthcare Access: Works to improve healthcare access, including the availability of compression therapy products.
• National Health Service (NHS), Wales
o Compression Therapy Services: Provides compression therapy services for conditions like venous leg ulcers and lymphedema.
o Patient Support: Offers patient support programs to enhance the effectiveness of compression therapy.
• World Health Organization (WHO)
o Global Health Statistics: Publishes global health statistics that highlight the prevalence of conditions treated with compression therapy.
o Healthcare Standards: Sets international healthcare standards that include the use of compression therapy for certain conditions.
Global Compression Therapy Market: Market Dynamics
Global Compression Therapy Market: Driving Factors
Rising prevalence of chronic venous disorders and lifestyle diseases
An increase in sedentary lifestyles, obesity, and aging populations has led to a surge in chronic venous insufficiency, varicose veins, and related vascular complications. This has significantly boosted the demand for compression stockings, bandages, and pneumatic compression devices as essential tools for improving venous return and preventing the progression of these conditions.
Growing awareness of early intervention in wound and vascular care
With the rising incidence of diabetic foot ulcers and pressure injuries, healthcare professionals are emphasizing early use of compression therapy to prevent complications and amputations. Hospitals and outpatient clinics are adopting compression solutions as part of chronic wound management protocols, reinforcing its clinical importance.
Global Compression Therapy Market: Restraints
Lack of adherence and discomfort associated with long-term use
Patient non-compliance remains a major barrier to effective compression therapy. Many individuals find compression garments uncomfortable or difficult to wear consistently, especially during warmer climates or extended daily activities, limiting the overall effectiveness of the treatment.
Limited access and affordability in low-resource settings
In several developing regions, high costs and a lack of healthcare infrastructure restrict access to quality compression therapy products. The absence of reimbursement policies and trained professionals further hampers the adoption of compression-based interventions for vascular and lymphatic disorders.
Global Compression Therapy Market: Opportunities
Expansion of home healthcare and self-managed treatment options
The growing preference for home-based care has opened new avenues for compression therapy, particularly with the availability of user-friendly pneumatic compression devices and compression wraps. This trend is enabling patients to manage conditions like lymphedema and post-surgical swelling without frequent clinic visits.
Technological innovations in smart compression systems
The integration of wearable sensors and mobile connectivity into compression garments is creating advanced solutions that monitor pressure levels and patient activity in real time. These smart compression systems are enhancing treatment personalization and compliance, making them attractive to both providers and consumers.
Global Compression Therapy Market: Trends
Increasing adoption of non-invasive and drug-free therapies
As patients and clinicians seek alternatives to surgery and medication, non-invasive options like compression therapy are becoming mainstream in vascular care and physical rehabilitation. This shift is particularly strong among older adults and those managing multiple chronic conditions.
Emphasis on aesthetic and functional design in compression wear
Manufacturers are focusing on producing compression garments that combine medical efficacy with appealing design, breathable fabrics, and ease of use. The rise of compression socks and sleeves for everyday wear reflects a broader trend of therapeutic wearables blending into lifestyle apparel.
Global Compression Therapy Market: Research Scope and Analysis
By Technique Analysis
Static Compression Therapy is projected to maintain a commanding position in the global compression therapy market, accounting for approximately 68.9% of the total market share in 2025. This technique involves the continuous application of consistent pressure to the affected area using compression garments such as stockings, bandages, wraps, and sleeves. It is widely adopted in the management of chronic venous insufficiency, varicose veins, venous leg ulcers, and lymphedema, primarily due to its simplicity, affordability, and high patient compliance in both clinical and home settings. Static compression enhances venous return, reduces edema, and promotes localized circulation, making it an integral component of long-term vascular health maintenance. Healthcare providers frequently prescribe medical-grade compression stockings for early intervention and to prevent progression of venous disorders, especially in aging populations and those with sedentary lifestyles or underlying metabolic conditions such as diabetes. Static therapy's dominance is further reinforced by the broad range of product types available on the market, including graduated compression garments that offer different pressure levels suited to various severity levels of vascular conditions.
On the other hand, Dynamic Compression Therapy represents a growing yet smaller segment of the market. Unlike static compression, dynamic systems use intermittent pneumatic compression devices (IPCs) that deliver controlled pressure in cycles, mimicking the natural muscle pump function. These devices are primarily used in hospital settings, rehabilitation centers, and in home healthcare environments for patients with severe lymphedema, post-surgical swelling, or those at high risk of thromboembolic events. Dynamic therapy is particularly beneficial in deep tissue stimulation, facilitating the mobilization of interstitial fluid and supporting wound healing in complex cases such as diabetic foot ulcers or chronic non-healing wounds. Although dynamic compression therapy accounts for a smaller portion of the market, its clinical efficacy and technological evolution are steadily improving its adoption. New-generation IPC devices are becoming more portable, patient-friendly, and integrated with digital tracking, aligning with the broader trend of smart therapeutic wearables.
By Product Analysis
Compression Bandages are projected to retain their leading position in the product type segment, securing an estimated 38.2% of the total market share in 2025. Their dominance is attributed to their widespread clinical usage, cost-effectiveness, and versatility in managing a range of conditions, including venous leg ulcers, chronic venous insufficiency, and post-traumatic swelling. Compression bandages offer controlled, sustained pressure and are particularly effective in wound care management, where they are often used in multilayer compression systems to optimize healing outcomes and reduce the risk of ulcer recurrence. Their adaptability to different limb shapes and sizes makes them a preferred choice in hospital settings, outpatient clinics, and community care environments. Medical practitioners frequently rely on short-stretch and long-stretch bandages, depending on the specific therapeutic goal, whether it is to maintain high working pressure for ambulatory patients or to provide steady resting pressure during immobility. Compression bandages are also extensively utilized in lymphatic drainage protocols, especially in the decongestive phase of lymphedema treatment. As awareness around chronic wound care and vascular health continues to grow, these bandages are expected to remain a cornerstone product across both developed and emerging healthcare markets.
On the other hand, Dynamic Compression Wraps are gaining attention as an advanced, patient-centric solution in the compression therapy landscape. These wraps utilize adjustable, often velcro-based systems, allowing patients or caregivers to apply therapeutic pressure with more precision and ease compared to traditional bandages. Unlike static bandages, dynamic wraps can be readjusted throughout the day without needing to be fully removed, enabling better pressure modulation and personalized care. They are especially useful in the maintenance phase of lymphedema therapy, venous reflux management, and in situations where frequent dressing changes are necessary due to exudative wounds. Dynamic compression wraps are used in home healthcare settings, driven by the rising trend of self-administered treatments and the growing emphasis on ambulatory wound care. These products offer a practical alternative for patients with limited mobility or dexterity, reducing dependence on skilled nursing visits while ensuring consistent therapeutic benefit. Some newer wraps are even integrated with pressure-indication markers and smart textiles, aligning with digital health trends aimed at improving patient adherence and treatment outcomes.
By Application Analysis
Varicose Veins treatment is expected to remain the leading application in the compression therapy market, accounting for approximately 34.5% of the total market share in 2025. This dominance is largely attributed to the high global prevalence of chronic venous insufficiency and venous reflux disorders, particularly among aging populations, sedentary workers, and individuals with hereditary predispositions. Varicose veins occur when the valves in the veins weaken, causing blood pooling and increased venous pressure, often resulting in pain, swelling, and visible vein bulging. Compression therapy, particularly through graduated compression stockings and wraps, has proven to be a first-line, non-invasive management approach to alleviate symptoms, improve vascular circulation, and prevent the condition from progressing to more severe forms such as venous leg ulcers. The convenience, affordability, and ease of application associated with compression garments have contributed significantly to their preference among patients and clinicians for treating varicose veins. Furthermore, the integration of compression therapy into lifestyle management, including during travel, pregnancy, or long work hours, has expanded its use in preventive care.
In parallel, Deep Vein Thrombosis (DVT) treatment forms a critical and expanding segment within the compression therapy market. DVT is a serious condition involving the formation of blood clots in deep veins, most commonly in the lower limbs. If left unmanaged, it can lead to pulmonary embolism, which is potentially life-threatening. In both hospital and home care settings, intermittent pneumatic compression (IPC) devices and compression stockings are widely used to prevent and treat DVT, particularly among post-surgical patients, bedridden individuals, and those with limited mobility. The application of compression therapy in DVT treatment enhances venous return, reduces venous stasis, and helps prevent thromboembolic complications. Hospitals often employ IPC systems during and after surgery to minimize clot formation risk, especially in orthopedic, cardiovascular, and oncological procedures. Additionally, long-term DVT patients benefit from medical-grade compression stockings that support deep vein valve function and prevent the development of post-thrombotic syndrome. As healthcare providers prioritize preventive vascular strategies, the role of compression therapy in DVT prevention and recovery is expanding, supported by clinical guidelines and growing reimbursement coverage.
By Distribution Channel Analysis
Hospitals and Clinics are expected to consolidate their leading role in the distribution channel type segment, securing approximately 52.8% of the market share in 2025. This dominance is primarily driven by the central role these institutions play in the diagnosis, treatment, and post-operative management of complex vascular and lymphatic conditions such as chronic venous insufficiency, venous leg ulcers, deep vein thrombosis (DVT), and lymphedema. Hospitals often serve as the first point of care where compression therapy is introduced under clinical supervision. Medical professionals in these settings typically prescribe pneumatic compression devices, custom-fitted compression garments, or multi-layer bandaging systems based on the patient's severity and treatment stage. Additionally, clinics and specialized wound care centers provide follow-up and maintenance care, often involving regular application, adjustment, or monitoring of compression therapy solutions. With the integration of smart therapeutic wearables and digitally monitored compression systems, hospitals are leveraging technology to track treatment adherence and optimize patient outcomes. The presence of trained staff, access to insurance reimbursements, and the ability to handle more severe or post-surgical cases further strengthen the position of hospitals and clinics as the preferred distribution point, especially in developed healthcare markets
Contents